Skip to main content

Table 2 Number of post-1981 drugs ever launched in Mexico, by cancer site, 1986–2013

From: The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013

ICD_WHO

1986

1989

1992

1995

1998

2001

2004

2007

2010

2013

C00–14 lip, oral cavity and pharynx

0

0

0

1

1

1

2

2

2

2

C15 oesophagus

0

0

0

1

1

2

2

2

2

2

C16 stomach

0

0

0

1

1

2

2

2

2

2

C18–21 colon, rectum and anus

0

0

0

0

1

2

4

5

5

6

C25 pancreas

0

0

0

1

3

3

3

6

6

6

C33–34 lung (incl. trachea and bronchus)

0

0

1

3

5

5

6

9

10

11

C43 melanoma of skin

0

1

1

1

2

3

3

3

3

5

C45 mesothelioma

0

0

0

0

0

0

0

1

1

1

C50 breast

0

1

2

4

7

11

12

13

16

16

C53 cervix uteri

0

0

0

0

0

0

0

1

2

2

C56 ovary

0

0

1

2

3

3

3

4

5

5

C61 prostate

0

3

4

5

6

6

6

6

7

8

C64 kidney

0

0

0

0

1

1

1

4

4

6

C70–72 brain, central nervous system

0

0

0

0

0

1

1

3

3

3

C73 thyroid

0

0

0

0

0

0

0

0

0

0

C81 hodgkin lymphoma

0

0

0

0

0

0

0

0

0

0

C82–85, C96 non-hodgkin lymphoma

0

1

1

1

1

2

2

3

5

5

C88 + C90 multiple myeloma

0

0

0

0

0

1

1

2

4

4

C91–95 leukemia

0

2

3

3

3

5

5

7

8

8

Mean

0.0

0.4

0.7

1.2

1.8

2.5

2.8

3.8

4.5

4.8